Determinants of the Formation and Activity of Factor V-phospholipid Complexes I. Influence of Phospholipid Structure

Carol L Kandall; Stephen B Shohet; T. K Akinbami; Robert W Colman

doi:10.1055/s-0038-1651339

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1975; 34(01): 256-270
DOI: 10.1055/s-0038-1651339

Original Article

Schattauer GmbH

Determinants of the Formation and Activity of Factor V-phospholipid Complexes I. Influence of Phospholipid Structure

Carol L Kandall

¹ Departments of Medicine and Pediatrics, Harvard Medical School, the Hematology Unit of the Massachusetts General Hospital, the Children’s Hospital Medical Center, Boston, Massachusetts

² University of San Francisco, Departments of Medicine and Clinical Pathology, Hematology Division, San Francisco, California 94122.

,

Stephen B Shohet

¹ Departments of Medicine and Pediatrics, Harvard Medical School, the Hematology Unit of the Massachusetts General Hospital, the Children’s Hospital Medical Center, Boston, Massachusetts

² University of San Francisco, Departments of Medicine and Clinical Pathology, Hematology Division, San Francisco, California 94122.

,

T. K Akinbami

¹ Departments of Medicine and Pediatrics, Harvard Medical School, the Hematology Unit of the Massachusetts General Hospital, the Children’s Hospital Medical Center, Boston, Massachusetts

² University of San Francisco, Departments of Medicine and Clinical Pathology, Hematology Division, San Francisco, California 94122.

,

Robert W Colman

¹ Departments of Medicine and Pediatrics, Harvard Medical School, the Hematology Unit of the Massachusetts General Hospital, the Children’s Hospital Medical Center, Boston, Massachusetts

² University of San Francisco, Departments of Medicine and Clinical Pathology, Hematology Division, San Francisco, California 94122.

› Institutsangaben

Abstract

Summary

Previous studies showed that factor V consists of multiple oligomeric forms including a minor component (form L) which contained lipid and was eluted in the excluded volume of a Sepharose 4B column. In the present and following study the hypothesis that factor V is a lipid requiring protein rather than a lipoprotein has been tested. Modification of a previous purification procedure resulted in the separation of factor V from lipoprotein. The lipid extracted from this lipoprotein was qualitatively similar to that previously isolated from form L. Removal of this lipoprotein by sucrose density gradient ultracentrifugation resulted in the isolation of factor V of high specific activity which contained no detectable phospholipid and less than 0.2% cholesterol. No component was excluded from Sepharose 4B after gel filtration of this purified preparation. It is concluded that factor V is not a lipoprotein, but rather a protein which requires lipid for its coagulant properties.

To define this requirement further the ability of factor V-phospholipid complexes to accelerate the conversion of prothrombin to thrombin by factor Xa in the presence of calcium was tested. The rate of thrombin formation was highly dependent on the phospholipid employed with each active phospholipid exhibiting a characteristic optimal concentration. At 250 μM, the order of activity was phosphatidyl ethanola-mine > phosphatidyl inositol > cardiolipin > phosphatidyl choline. Phosphatidyl serine was inert at all concentrations employed. No single fatty acid was consistently present in active lipid preparations, nor was a specific fatty acid absent from those which had no clotting activity. In comparing different lipid classes, a direct relationship between the overall degree of unsaturation and activity was not observed. However, bovine phosphatidyl inositol, which is highly unsaturated, is active, while plant phosphatidyl inositol, which contains only trace amounts of unsaturated fatty acids, was inert. At lipid concentrations below 300 μM, saturated phosphatidyl ethanolamine produced by hydrogenation of bovine phosphatidyl ethanolamine was less active than an equal concentration of the native lipid. In mixtures containing both lipids, artificially saturated phosphatidyl ethanolamine potentiated the activity of the native compound.

Volltext

Referenzen

References
1 Alkjaersig N, Fletcher A. P, and Sherry S. 1959; ε-amino caproic acid: An inhibitor of plasminogen activation. Journal of Biological Chemistry 234: 832.
2 Barton P. D. 1969. Lipoproteins of blood coagulation. In: Tria E, and Scanu A. M. (Eds.) Structural and functional aspects of lipoproteins in living systems. New York: Academic Press; 465.
3 Colman R. W. 1969; The effect of proteolytic enzymes on bovine factor V. I. Kinetics of activation and inactivation by bovine thrombin. Biochemistry 8: 1438.
4 Day W. C, and Barton P. G. 1972; Studies on the stability of bovine plasma factor V. Biochimica et Biophysica Acta 261: 457.
5 Dodge J. T, and Phillips G. B. 1967; Composition of phospholipids and of phospholipid fatty acids and aldehydes in human red cells. Journal of Lipid Research 8: 667.
6 Eichberg J, and Burnham J. D. 1970; Novel preparation of cardiolipin from beef heart. Journal of Lipid Research 11: 386.
7 Fleischer B, Sekuzu I, and Fleischer S. 1967; Interaction of the protein moiety of bovine serum α-lipoprotein with phospholipid micelles. I. The use of lipid-requiring enzymes as assay systems. Biochimica et Biophysica Acta 147: 552.
8 Folch M, Lees M, and Stanley G. H. S. 1957; A simple method for the isolation and purification of total lipids from animal tissues. Journal of Biological Chemistry 226: 497.
9 Gornall A. G, Bardawill C. J, and Maxima M. D. 1949; Determination of serum proteins by means of the Biuret reaction. Journal of Biological Chemistry 177: 751.
10 Hanahan D. J, Watts P. M, and Papajohn D. 1960; Some chemical characteristics of the lipids of human and bovine erythrocytes and plasma. Journal of Lipid Research 1: 421.
11 Iatridis P. G, and Ferguson J. H. 1965; The plasmatic atmosphere of blood platelets. Evidence that only fibrinogen, AcG, and activated Hageman factor are present on the surface of platelets. Thrombosis et Diathesis Haemorrhagica 13: 114.
12 Jackson C. M, Johnson T. F, and Hanahan D. J. 1968; Studies on bovine factor X. Large scale purification of the bovine plasma protein possessing factor X activity. Biochemistry 7: 4492.
13 Kandall C. L, Akinbami T. K, and Colman R. W. 1972; Determinants of prothrombinase activity and modification of prothrombin conversion by thrombin-treated factor V. British Journal of Hematology 23: 655.
14 Kandall C. L, Akinbami T. K, Shohet S, and Colman R. W. 1971; Determinants of formation and activity of phospholipid-factor V complexes. Federation Proceedings 30: 1075.
15 Kandall C. L, Shohet S. B, Akinbami T. K, and Colman R. W. 1975; Determinants of the formation and activity of factor V-phospholipid complexes. II. Molecular properties of the complexes. Thrombosis et Diathesis Haemorrhagica 34: 271.
16 Leat W. F. 1966; Fatty acid composition of the plasma lipids of newborn and maternal ruminants. Biochemical Journal 98: 598.
17 Leat W. F, and Batar J. 1970; Distribution of fatty acids in the plasma lipids of herbivores grazing pasture: a species comparison. Comparative Biochemistry and Physiology 36: 153.
18 Lowry O. H, Roberts N. R, Leiner K. Y, Wu M. L, and Farr A. L. 1954; The quantitative histochemistry of brain. I. Chemical methods. Journal of Biological Chemistry 207: 1.
19 Mangold H. K. 1965. Aliphatic lipids. III. Separation of lipids according to their degree of unsaturation. In: Egon Stahl (Editor). Thin layer chromatography. Berlin: Springer-Verlag; 174.
20 Marcus A. J. 1966. The role of lipids in blood coagulation. In: Advances in lipid research, Vol. 4. New York: Academic Press; 1.
21 Morrison W. R, and Smith L. M. 1964; Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoridemethanol. Journal of Lipid Research 5: 600.
22 Nemerson Y. 1968; The phospholipid requirement of tissue factor in blood coagulation. Journal of Clinical Investigation 47: 72.
23 Owren P. A, and Aas K. 1951; The control of dicoumarol therapy and the quantitative determination of prothrombin and proconvertin. Scandinavian Journal of Clinical and Laboratory Investigation 3: 201.
24 Papahadjopoulos D, Houghie C, and Hanahan D. J. 1962; Influence of surface charge of phospholipids on their clot-promoting activity. Proceedings of the Society of Experimental Medicine and Biology 111: 412.
25 Papahadjopoulos D, Houghie E, and Hanahan D. J. 1964; Purification and properties of bovine factor V: A change of molecular size during blood coagulation. Biochemistry 3: 264.
26 Parker F, and Peterson N. F. 1967; Quantitative analysis of phospholipids and phospholipid fatty acids from silica gel thin layer chromatography. Journal of Lipid Research 6: 455.
27 Philip G, Moran J, and Colman R. W. 1970; Dissociation and association of the oligomeric forms of factor V. Biochemistry 9: 2212.
28 Robinson N. 1960; A light scattering study of lecithin. Trans. Far. Soc 56: 1260.
29 Rouser G, White S. G, and Schloredt D. 1958; Phospholipid structure and thrombo-plastic activity. II. The fatty acid composition of the active phosphatidyl ethanolamines. Biochemica et Biophysica Acta 28: 81.
30 Schmer G, Kirby E. P, Teller D. C, and Davie E. W. 1972; The isolation and characterization of bovine factor VIII (anti-hemophilic factor). Journal of Biological Chemistry 247: 2512.
31 Skipski V. P, Good J. J, Barclay M, and Beggio R. B. 1968; Quantitative analysis of simple lipid classes by thin-layer chromatography. Biochemica et Biophysica Acta 152: 10.
32 Skipski V. P, Peterson B. F, and Barclay M. 1964; Quantitative analysis of phospholipids by thin-layer chromatography. Biochemical Journal 90: 374.
33 Tishkoff G. H, Williams L. C, and Brown D. M. 1968; Preparation of highly purified prothrombin complex. I. Crystallization, biological activity, and molecular properties. Journal of Biological Chemistry 243: 4151.
34 Wallach D. F, Maurice P. A, Steele B. B, and Surgenor D. M. 1959; Studies on the relationship between the colloid state and clotpromoting activity. Journal of Biological Chemistry 234: 2829.
35 Wybenga D. R, Pileggi V. J, Durstine P. H, and DiGiorgio J. 1970; Direct manual determination of serum total cholesterol with a stable reagent. Clinical Chemistry 16: 980.
36 Yin E. T, and Wessler S. 1968; Bovine thrombin and activated factor X. Journal of Biological Chemistry 243: 112.
37 Zlatkis A, Zak G, and Boyle A. J. 1953; A new method for the direct determination of serum cholesterol. Journal of Laboratory and Clinical Medicine 41: 486.